Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Positive Keytruda lung cancer data sends Merck shares up

      Positive Keytruda lung cancer data sends Merck shares up

      Ruby Khatun Khatun19 Jan 2018 10:00 AM IST
      Positive lung cancer results for Merck & Co Inc’s blockbuster drug Keytruda assuaged investor concerns about delays in testing and the withdrawal...
      Johnson and Johnson attracts Chinese interest for diabetes business in potential 3-4 billion dollars deal: sources

      Johnson and Johnson attracts Chinese interest for diabetes business in potential 3-4 billion dollars deal: sources

      Ruby Khatun Khatun19 Jan 2018 9:45 AM IST
      HONG KONG: Chinese bidders are circling a diabetes care business owned by the world's largest healthcare company Johnson and Johnson in a deal that...
      DRL recalls over 1000 vials of cancer drug from US

      DRL recalls over 1000 vials of cancer drug from US

      Ruby Khatun Khatun18 Jan 2018 11:00 AM IST
      New Delhi: Pharmaceuticals major Dr. Reddy's Laboratories (DRL) has recalled a single lot of Docetaxel injection vials, used for the treatment of...
      Jubilant Life Sciences Q3 net up 80 percent to Rs 212.84 crore

      Jubilant Life Sciences Q3 net up 80 percent to Rs 212.84 crore

      Ruby Khatun Khatun18 Jan 2018 10:45 AM IST
      New Delhi: Drug firm Jubilant Life Sciences reported an 80.20 percent rise in its consolidated net profit to Rs 212.84 crore for the third quarter...
      Patanjali to set up five institutes in Nagaland

      Patanjali to set up five institutes in Nagaland

      Ruby Khatun Khatun18 Jan 2018 10:30 AM IST
      Kohima: Nagaland State Chief Minister T R Zeliang announced a slew of investments made by the Patanjali Group in the state, after laying foundation...
      JB Chemicals and Pharmas Gujarat facilities get European nod

      JB Chemicals and Pharma's Gujarat facilities get European nod

      Ruby Khatun Khatun18 Jan 2018 10:30 AM IST
      New Delhi: JB Chemicals and Pharmaceuticals said the Medicines Authority of Malta has granted European GMP approval to its manufacturing facilities...
      Tata Trusts launches Impact Lab for public health

      Tata Trusts launches Impact Lab for public health

      Ruby Khatun Khatun18 Jan 2018 10:15 AM IST
      New Delhi: Tata Trusts said it has set up an 'Impact Lab' at IIT Delhi in partnership with health innovation player PATH for healthcare solutions in...
      US court invalidates patent on Johnson and Johnson cancer drug Zytiga

      US court invalidates patent on Johnson and Johnson cancer drug Zytiga

      Ruby Khatun Khatun18 Jan 2018 10:00 AM IST
      NEW YORK: A U.S. administrative court on Wednesday invalidated a Johnson and Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing...
      UK drugs regulator plays down Brexit disruption threat

      UK drugs regulator plays down Brexit disruption threat

      Ruby Khatun Khatun18 Jan 2018 9:30 AM IST
      LONDON: Britain’s drugs regulator said on Tuesday it would work to minimise disruption caused by the country leaving the European Union as it tried to...
      NPPA fixes ceiling prices of 33 more drugs, check out details

      NPPA fixes ceiling prices of 33 more drugs, check out details

      Ruby Khatun Khatun17 Jan 2018 2:08 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Patanjali ties up with Amazon, Flipkart, 1mg, Netmeds, Paytm Mall to push ayurveda products

      Patanjali ties up with Amazon, Flipkart, 1mg, Netmeds, Paytm Mall to push ayurveda products

      Ruby Khatun Khatun17 Jan 2018 11:00 AM IST
      New Delhi: Baba Ramdev-led Patanjali Ayurved announced its partnership with eight online platforms in a move to push sales of its range of...
      A 300 billion dollars reason to keep drugs cheap in India: Report

      A 300 billion dollars reason to keep drugs cheap in India: Report

      Ruby Khatun Khatun17 Jan 2018 10:45 AM IST
      Global pharmaceutical companies have bemoaned for years India's capricious policies on prices and patents. Now the government needs billions of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok